Jake Siegel has a diverse range of work experience spanning various roles in the field of computational biology and data science. Jake currently holds the position of Director of Computational Biology and Data Science at Metaphore Biotechnologies since October 2022. Prior to this, they were Head of Integrated Data Sciences at Roivant Sciences from July 2021 to October 2022. Before that, they served as Sr. Principal Scientist & Head of Computational Biology at Immunitas Therapeutics from June 2020 to June 2021. Jake also worked as a Computational Scientist II at Repertoire Immune Medicines from February 2018 to June 2020.
In addition to their industry roles, Jake Siegel has also gained research experience. Jake was a Health Data Fellow at Insight Data Science from September 2017 to January 2018, where they completed a consulting project for a targeted genomics company. Prior to that, they worked as a Postdoctoral Research Scientist at the Massachusetts Institute of Technology (MIT) from 2015 to 2017, where they studied exciton physics in semiconductor nanomaterials using nonlinear ultrafast spectroscopy. Jake also worked as a Research Specialist in Quantitative Genomics at the David Geffen School of Medicine at UCLA from 2013 to 2014, and as a Postdoctoral Associate in Cancer Systems Biology at MIT from 2010 to 2012.
Jake Siegel's academic background includes being a Graduate Student in Biophysics at the University of California, Berkeley from 2003 to 2009, where they developed new optical techniques and probes to characterize nucleo-cytoplasmic transport in cells and the bending of DNA. Jake also worked as an Associate Scientist in Automated Bloodborne Disease Diagnostics at Roche Molecular Systems from 2002 to 2003, where they contributed to the development of an automated Hepatitis B bloodborne viral load assay.
Overall, Jake Siegel brings a wealth of expertise and experience in computational biology, data science, and research to their current role as Director of Computational Biology and Data Science at Metaphore Biotechnologies.
In 1999, Jake Siegel began their education at the University of California, Berkeley and completed a Bachelor of Arts (BA) degree in Molecular and Cell Biology in 2001. Continuing their academic journey, they pursued a Doctor of Philosophy (Ph.D.) degree in Biophysics at the same institution from 2003 to 2009.
Sign up to view 8 direct reports
Get started